Lilly's Oral GLP-1, Orforglipron, Demonstrated Statistically Significant Efficacy Results
Call 999 or go to A&E immediately if you experience signs of a serious allergic reaction (widespread rash, difficulty breathing, facial or throat swelling)
Am J Transl Res
This is the question most people ask first, and its a good one because contrave for weight loss works differently from GLP-1 medications like semaglutide or tirzepatide
If you are new to exercise or have medical concerns, consult your healthcare provider before starting a new program
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8